Left Atrial Appendage Exclusion for Atrial Fibrillation

Faisal F. Syed, Christopher V. DeSimone, Paul Andrew Friedman, Samuel J Asirvatham

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Percutaneous left atrial appendage (LAA) closure is being increasingly used as a treatment strategy to prevent stroke in patients with atrial fibrillation (AF) who have contraindications to anticoagulants. Several approaches and devices have been developed in the last few years, each with their own unique set of advantages and disadvantages. In this article, the published studies on surgical and percutaneous approaches to LAA closure are reviewed, focusing on stroke mechanisms in AF, LAA structure and function relevant to stroke prevention, practical differences in procedural approach, and clinical considerations surrounding management.

Original languageEnglish (US)
Pages (from-to)273-297
Number of pages25
JournalHeart Failure Clinics
Volume12
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Atrial Appendage
Atrial Fibrillation
Stroke
Atrial Function
Anticoagulants
Equipment and Supplies
Therapeutics

Keywords

  • Atrial fibrillation
  • Left atrial appendage
  • Percutaneous appendage closure
  • Stroke prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Left Atrial Appendage Exclusion for Atrial Fibrillation. / Syed, Faisal F.; DeSimone, Christopher V.; Friedman, Paul Andrew; Asirvatham, Samuel J.

In: Heart Failure Clinics, Vol. 12, No. 2, 01.04.2016, p. 273-297.

Research output: Contribution to journalArticle

Syed, Faisal F. ; DeSimone, Christopher V. ; Friedman, Paul Andrew ; Asirvatham, Samuel J. / Left Atrial Appendage Exclusion for Atrial Fibrillation. In: Heart Failure Clinics. 2016 ; Vol. 12, No. 2. pp. 273-297.
@article{7978e5e78a3344f2826051cd84a1cac9,
title = "Left Atrial Appendage Exclusion for Atrial Fibrillation",
abstract = "Percutaneous left atrial appendage (LAA) closure is being increasingly used as a treatment strategy to prevent stroke in patients with atrial fibrillation (AF) who have contraindications to anticoagulants. Several approaches and devices have been developed in the last few years, each with their own unique set of advantages and disadvantages. In this article, the published studies on surgical and percutaneous approaches to LAA closure are reviewed, focusing on stroke mechanisms in AF, LAA structure and function relevant to stroke prevention, practical differences in procedural approach, and clinical considerations surrounding management.",
keywords = "Atrial fibrillation, Left atrial appendage, Percutaneous appendage closure, Stroke prevention",
author = "Syed, {Faisal F.} and DeSimone, {Christopher V.} and Friedman, {Paul Andrew} and Asirvatham, {Samuel J}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.hfc.2015.08.022",
language = "English (US)",
volume = "12",
pages = "273--297",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Left Atrial Appendage Exclusion for Atrial Fibrillation

AU - Syed, Faisal F.

AU - DeSimone, Christopher V.

AU - Friedman, Paul Andrew

AU - Asirvatham, Samuel J

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Percutaneous left atrial appendage (LAA) closure is being increasingly used as a treatment strategy to prevent stroke in patients with atrial fibrillation (AF) who have contraindications to anticoagulants. Several approaches and devices have been developed in the last few years, each with their own unique set of advantages and disadvantages. In this article, the published studies on surgical and percutaneous approaches to LAA closure are reviewed, focusing on stroke mechanisms in AF, LAA structure and function relevant to stroke prevention, practical differences in procedural approach, and clinical considerations surrounding management.

AB - Percutaneous left atrial appendage (LAA) closure is being increasingly used as a treatment strategy to prevent stroke in patients with atrial fibrillation (AF) who have contraindications to anticoagulants. Several approaches and devices have been developed in the last few years, each with their own unique set of advantages and disadvantages. In this article, the published studies on surgical and percutaneous approaches to LAA closure are reviewed, focusing on stroke mechanisms in AF, LAA structure and function relevant to stroke prevention, practical differences in procedural approach, and clinical considerations surrounding management.

KW - Atrial fibrillation

KW - Left atrial appendage

KW - Percutaneous appendage closure

KW - Stroke prevention

UR - http://www.scopus.com/inward/record.url?scp=84960108815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960108815&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2015.08.022

DO - 10.1016/j.hfc.2015.08.022

M3 - Article

VL - 12

SP - 273

EP - 297

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 2

ER -